Diagnosis and classification of pemphigus and bullous pemphigoid

Autoimmunity Reviews

Volumn 13, Issue 4-5, 2014, Pages 477-481

  Kershenovich, Ruben ^a   Hodak, Emmilia ^a,b   Mimouni, Daniel ^a,b  

^a RABIN MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Bullous pemphigoid; Clinical classification; Criteria; Diagnosis; Pemphigus

Indexed keywords

AUTOANTIBODY;

ACANTHOLYSIS; AUTOIMMUNE DISEASE; BLISTER; BULLOUS PEMPHIGOID; CELL SURFACE; DERMOEPIDERMAL JUNCTION; DIAGNOSTIC TEST; ENZYME LINKED IMMUNOSORBENT ASSAY; HEMIDESMOSOME; HISTOPATHOLOGY; HUMAN; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; IMMUNOPATHOLOGY; IMMUNOPRECIPITATION; KERATINOCYTE; NONHUMAN; PARANEOPLASTIC PEMPHIGUS; PATHOGENESIS; PEMPHIGUS; PEMPHIGUS FOLIACEUS; PEMPHIGUS VULGARIS; REVIEW; SKIN BIOPSY;

BULLOUS PEMPHIGOID; CLINICAL CLASSIFICATION; CRITERIA; DIAGNOSIS; PEMPHIGUS;

AUTOANTIBODIES; AUTOIMMUNE DISEASES; BIOPSY; HUMANS; PEMPHIGOID, BULLOUS; PEMPHIGUS;

EID: 84896320110     PISSN: 15689972     EISSN: 18730183     Source Type: Journal    
DOI: 10.1016/j.autrev.2014.01.011     Document Type: Review

References (41)

1. Nousari H.C., Anhalt G.J. Pemphigus and bullous pemphigoid. Lancet 1999, 354:667-672.
2. Stanley J.R., Hawley-Nelson P., Yuspa S.H., Shevach E.M., Katz S.I. Characterization of bullous pemphigoid antigen: a unique basement membrane protein of stratified squamous epithelia. Cell 1981, 24:897-903.
3. Stanley J.R., Amagai M. Autoimmune bullous diseases: historical perspectives. J Invest Dermatol 2008, 128:E16-E18.
4. Beutner E.H., Jordon R.E. Demonstration of skin antibodies in sera of pemphigus vulgaris patients by indirect immunofluorescent staining. Proc Soc Exp Biol Med 1964, 117:505-510.
5. Lever W.F. Pemphigus. Medicine 1953, 32:1-123.
6. Ruocco V., Ruocco E., Lo Schiavo A., Brunetti G., Guerrera L.P., Wolf R. Pemphigus: etiology, pathogenesis, and inducing or triggering factors: facts and controversies. Clin Dermatol 2013, 31:374-381.
7. Joly P., Litrowski N. Pemphigus group (vulgaris, vegetans, foliaceus, herpetiformis, brasiliensis). Clin Dermatol 2001, 29:432-436.
8. Wang J., Zhu X., Li R., Tu P., Wang R., Zhang L., et al. Paraneoplastic pemphigus associated with Castleman tumor: a commonly reported subtype of paraneoplastic pemphigus in China. Arch Dermatol 2005, 141:1285-1293.
9. Wang J., Bu D.F., Li T., Zheng R., Zhang B.X., Chen X.X., et al. Autoantibody production from a thymoma and a follicular dendritic cell sarcoma associated with paraneoplastic pemphigus. Br J Dermatol 2005, 153:558-564.
10. Schmidt E., Zillikens D. Pemphigoid diseases. Lancet 2013, 381:320-332.
11. Hu C.H., Michel B., Schiltz J.R. Epidermal acantholysis induced in vitro by pemphigus autoantibody. An ultrastructural study. Am J Pathol 1978, 90:345-362.
12. Anhalt G.J., Labib R.S., Voorhees J.J., Beals T.F., Diaz L.A. Induction of pemphigus in neonatal mice by passive transfer of IgG from patients with the disease. N Engl J Med 1982, 306:1189-1196.
13. Stanley J.R., Koulu L., Klaus-Kovtun V., Steinberg M.S. A monoclonal antibody to the desmosomal glycoprotein desmoglein I binds the same polypeptide as human autoantibodies in pemphigus foliaceus. J Immunol 1986, 136:1227-1230.
14. Eyre R.W., Stanley J.R. Human autoantibodies against a desmosomal protein complex with a calcium-sensitive epitope are characteristic of pemphigus foliaceus patients. J Exp Med 1987, 165:1719-1724.
15. Stanley J.R., Koulu L., Klaus-Kovtun V., Steinberg M.S. A monoclonal antibody to the desmosomal glycoprotein desmoglein I binds the same polypeptide as human autoantibodies in pemphigus foliaceus. J Immunol 1986, 136:1227-1230.
16. Koulu L., Kusumi A., Steinberg M.S., Klaus-Kovtun V., Stanley J.R. Human autoantibodies against a desmosomal core protein in pemphigus foliaceus. J Exp Med 1984, 160:1509-1518.
17. Stanley J.R., Koulu L., Thivolet C. Distinction between epidermal antigens binding pemphigus vulgaris and pemphigus foliaceus autoantibodies. J Clin Invest 1984, 74:313-320.
18. Amagai M., Klaus-Kovtun V., Stanley J.R. Autoantibodies against a novel epithelial cadherin in pemphigus vulgaris, a disease of cell adhesion. Cell 1991, 29:869-877.
19. Mahoney M.G., Wang Z., Rothenberger K., Koch P.J., Amagai M., Stanley J.R. Explanations for the clinical and microscopic localization of lesions in pemphigus foliaceus and vulgaris. J Clin Invest 1999, 103:461-468. J Clin Invest. 1999 Feb;103(4):461-8.
20. Hertl M., Zillikens D. Clinical and molecular characterization of autoimmune bullous diseases. J Invest Dermatol 2008, 128:E19-E21.
21. Hashimoto T., Amagai M., Watanabe K., Chorzelski T.P., Bhogal B.S., Black M.M., et al. Characterization of paraneoplastic pemphigus autoantigens by immunoblot analysis. J Invest Dermatol 1995, 104:829-834.
22. Nagata Y., Karashima T., Watt F.M., Salmhofer W., Kanzaki T., Hashimoto T. Paraneoplastic pemphigus sera react strongly with multiple epitopes on the various regions of envoplakin and periplakin, except for the c-terminal homologous domain of periplakin. J Invest Dermatol 2001, 116:556-563.
23. Zhang B., Zheng R., Wang J., Bu D., Zhu X. Epitopes in the linker subdomain region of envoplakin recognized by autoantibodies in paraneoplastic pemphigus patients. J Invest Dermatol 2006, 126:832-840.
24. Schepens I., Jaunin F., Begre N., Läderach U., Marcus K., Hashimoto T., et al. The protease inhibitor alpha-2-macroglobulin-like-1 is the p170 antigen recognized by paraneoplastic pemphigus autoantibodies in human. PLoS One 2010, 5:e12250.
25. Labib R.S., Anhalt G.J., Patel H.P., Mutasim D.F., Diaz L.A. Molecular heterogeneity of the bullous pemphigoid antigens as detected by immunoblotting. J Immunol 1986, 136:1231-1235.
26. Stanley J.R., Hawley-Nelson P., Yuspa S.H., Shevach E.M., Katz S.I. Characterization of bullous pemphigoid antigen: a unique basement membrane protein of stratified squamous epithelia. Cell 1981, 24:897-903.
27. Mueller S., Klaus-Kovtun V., Stanley J.R. A 230-kD basic protein is the major bullous pemphigoid antigen. J Invest Dermatol 1989, 92:33-38.
28. Thoma-Uszynski S., Uter W., Schwietzke S., Schuler G., Borradori L., Hertl M. Autoreactive T and B cells from bullous pemphigoid (BP) patients recognize epitopes clustered in distinct regions of BP180 and BP230. J Immunol 2006, 176:2015-2023.
29. Liu Z., Shipley J.M., Vu T.H., Zhou X., Diaz L.A., Werb Z., et al. Gelatinase B-deficient mice are resistant to experimental bullous pemphigoid. J Exp Med 1998, 188:475-482.
30. Liu Z., Shapiro S.D., Zhou X., Twining S.S., Senior R.M., Giudice G.J., et al. A critical role for neutrophil elastase in experimental bullous pemphigoid. J Clin Invest 2000, 105:113-123.
31. Anhalt Grant J. Paraneoplastic pemphigus. J Investig Dermatol Symp Proc 2004, 9:29-33.
32. Beutner E.H., Lever W.F., Witebsky E. Autoantibodies in pemphigus vulgaris. Response to an intercellular substance of epidermis. JAMA 1965, 92:682-688.
33. Liu A.Y., Valenzuela R., Helm T.N., Camisa C., Melton A.L., Bergfeld W.F. Indirect immunofluoresence on rat transitional epithelium: a test with high specificity for paraneoplastic pemphigus. J Am Acad Dermatol 1993, 28:696-699.
34. Harman K.E., Gratian M.J., Seed P.T., Bhogal B.S., Challacombe S.J., Black M.M. Diagnosis of pemphigus by ELISA: a critical evaluation of two ELISAs for the detection of antibodies to the major pemphigus antigens, desmoglein 1 and 3. Clin Exp Dermatol 2000, 25:236-240.
35. Poot A.M., Diercks G.F.H., Kramer D., Schepens I., Klunder G., Hashimoto T., et al. Laboratory diagnosis of paraneoplastic pemphigus. Br J Dermatol 2013, [Epub ahead of print]. 10.1111/bjd.12479.
36. Ghohestani R., Kanitakis J., Nicolas J.F., Cozzani E., Claudy A. Comparative sensitivity of indirect immunofluorescence to immunoblot assay for the detection of circulating antibodies to bullous pemphigoid antigens 1 and 2. Br J Dermatol 1996, 135:74-79.
37. Giudice G.J., Wilske K.C., Anhalt G.J., Fairley J.A., Taylor A.F., Emery D.J., et al. Development of an ELISA to detect anti-BP180 autoantibodies in bullous pemphigoid and herpes gestationis. J Invest Dermatol 1994, 102:878-881.
38. Zillikens D., Mascaro J.M., Rose P.A., Liu Z., Ewing S.M., Caux F., et al. A highly sensitive enzyme-linked immunosorbent assay for the detection of circulating anti-BP180 autoantibodies in patients with bullous pemphigoid. J Invest Dermatol 1997, 109:679-683.
39. Haase C., Budinger L., Borradori L., Yee C., Merk H.F., Yancey K., et al. Detection of IgG autoantibodies in the sera of patients with bullous and gestational pemphigoid: ELISA studies utilizing a baculovirus-encoded form of bullous pemphigoid antigen 2. J Invest Dermatol 1998, 110:282-286.
40. Kobayashi M., Amagai M., Kuroda-Kinoshita K., Hashimoto T., Shirakata Y., Hashimoto K., et al. BP180 ELISA using bacterial recombinant NC16a protein as a diagnostic and monitoring tool for bullous pemphigoid. J Dermatol Sci 2002, 30:224-232.
41. Mariotti F., Grosso F., Terracina M., Ruffelli M., Cordiali-Fei P., Sera F., et al. Development of a novel ELISA system for detection of anti-BP180 IgG and characterization of autoantibody profile in bullous pemphigoid patients. Br J Dermatol 2004, 151:1004-1010.